Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 3.420 | 3.440 | 0.020 |
Shares | 96.580 | 96.580 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 18.088 | 18.989 |
Price to Book | 3.477 | 3.152 |
Price to Sales | 1.594 | 2.240 |
Price to Cash Flow | 10.853 | 12.699 |
Dividend Yield | 2.016 | 1.897 |
5 Years Earnings Growth | 9.404 | 11.381 |
Name | Net % | Category Average |
---|---|---|
Industrials | 19.050 | 13.716 |
Financial Services | 18.050 | 16.501 |
Technology | 17.450 | 20.972 |
Consumer Cyclical | 16.500 | 11.379 |
Communication Services | 11.880 | 8.806 |
Healthcare | 9.610 | 13.695 |
Consumer Defensive | 7.460 | 7.847 |
Number of long holdings: 60
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Publicis Groupe | FR0000130577 | 5.41 | 105.75 | -1.08% | |
Marsh & McLennan Companies Inc | - | 4.72 | - | - | |
Microsoft Corp | - | 4.25 | - | - | |
Alimentation Couche-Tard Inc | - | 4.01 | - | - | |
Wolters Kluwer | NL0000395903 | 3.72 | 146.60 | +0.10% | |
UnitedHealth Group Inc | - | 3.64 | - | - | |
CGI Inc Class A | - | 3.52 | - | - | |
Novo Nordisk B | DK0062498333 | 3.39 | 903.3 | -1.05% | |
Aon | IE00BLP1HW54 | 3.25 | 292.36 | +0.12% | |
CDW Corp | - | 3.00 | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Manulife Div incm Fd Sr Adv | 7.14B | 5.51 | 3.78 | 9.05 | ||
Manulife Div incm Fd Sr F | 7.14B | 5.91 | 4.95 | 10.27 | ||
Manulife Div incm Fd Sr T6 | 7.14B | 5.51 | 3.77 | 9.04 | ||
Manulife Div incm Fd Sr FT6 | 7.14B | 5.91 | 4.94 | 10.27 | ||
Manulife Glbl Eq Cl Sr F | 6.82B | 3.85 | 7.83 | 11.03 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review